Skip to main content
Animated patient portrayal of a mother and son hiking

PROMACTA is the #1 prescribed platelet booster, taken by more than 500,000 people worldwide across indications.*,†

*PROMACTA has been proven to work for children over the age of 1 year with persistent or chronic ITP.
Source: IQVIA prescription claims data for March 2021 through August 2022. Includes people with chronic immune thrombocytopenia, severe aplastic anemia, and chronic hepatitis C virus.

Watch stories of PROMACTA from people like you

PROMACTA has helped many different kinds of people, and we have some of their stories to share. Below, meet Kailey and get inspired by the story of her treatment with PROMACTA.

Meet Ella, living with chronic ITP, and her mom, Meg

Meet Ella, living with chronic ITP, and her mom, Meg